High rates of chlamydia in patients referred for termination of pregnancy: Treatment, contact tracing, and implications for screening

New Zealand Medical Journal

Volumn 118, Issue 1211, 2005, Pages

  Rose, Sally ^a   Lawton, Beverley ^a   Brown, Selina ^a   Goodyear Smith, Felicity ^b   Arroll, Bruce ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ADOLESCENT; ADULT; AGE; ARTICLE; ASIAN; CAUCASIAN; CHLAMYDIASIS; CONDYLOMA; CONTACT EXAMINATION; CONTRACEPTION; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; GONORRHEA; HEALTH EDUCATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MAORI; MARRIAGE; MEDICAL AUDIT; NEW ZEALAND; PATIENT REFERRAL; PRACTICE GUIDELINE; PREGNANCY TERMINATION; RETROSPECTIVE STUDY; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; ABORIGINE; AGE DISTRIBUTION; INDUCED ABORTION; MIDDLE AGED; PARITY; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; RISK FACTOR;

ABORTION, INDUCED; ADOLESCENT; ADULT; AGE DISTRIBUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CHLAMYDIA INFECTIONS; CONTACT TRACING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 21244450047     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abortion Supervisory Committee. 26th Annual report of the Abortion Supervisory Committee for 2003. Presented to the House of Representatives pursuant to Section 39 of the Contraception, Sterilisation and Abortion Act 1977: New Zealand, 2003.
2. Allsop JR. Termination of pregnancy. Current Obstetrics & Gynaecology. 2004;14:285-90.
3. Low M, Egger M. What should we do about screening for genital chlamydia? Int J Epi. 2002;31:891-3.
4. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. Geneva: WHO; 2001. Available online. URL: http://www.who.int/reproductive-health/publications/Abstracts/ prevalence.html Accessed March 2005.
5. Population and Environmental Health Group. Sexually Transmitted Infections in New Zealand. Annual Surveillance Report 2003. Porirua: Institute of Environmental Science and Research Limited; 2004:1-48. Available online. URL: http://www.surv.esr.cri.nz/PDF_surveillance/STISurvRpt/2003/ STIAnnualReport2003.pdf Accessed March 2005.
6. Blackwell AL, Thomas PD, Emery SJ, Wareham K. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993;342:206-10.
7. Mardh P-A. Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Pract Res Clin Obstet Gynaecol. 2002;16:847-64.
8. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362-6.
9. Mallinson H, Hopwood J, Skidmore S, et al. Provision of Chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Trans Dis. 2002;78:416-21.
10. Groom TM, Stewart P, Kruger H, Bell G. The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy. J Fam Plan Repro Hlth Care. 2001;27:69-72.
11. Acharya G, Morgan H, Paramanantham L, Fernando R. A randomised controlled trial comparing surgical termination of pregnancy with and without continuous ultrasound guidance. Euro J Ob Gyn Repro Biol. 2004;114:69-74.
12. Blackwell AL, Emery SJ, Thomas PD, Wareham K. Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains. Int J STD AIDS. 1999;10:508-13.
13. Chen SM, van den Hoek A, Shao CG, et al. Prevalence of and risk indicators for STIs among women seeking induced abortions in two urban family planning clinics in Shandong province, People's Republic of China. Sex Transm Infect. 2002;78(e3). Available online. URL: http://www.sextransinf.com/cgi/content/full/78/3/e3 Accessed March 2005.
14. Mortegul AJ, Meyer MP, Gnatuk CL. Prevalence of Chlamydia trachomatis and other microorganisms in women seeking abortions in Pittsburgh, Pennsylvania, United States of America. Genitourin Med. 1986;62:88-92.
15. Stray-Pederson B, Biornstad J, Dahl M, et al. Induced abortion: microbiological screening and medical complications. Infection. 1991;19:305-8.
16. Garland SM, Tabrizi S, Hallo J, Chen S. Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy. Sex Transm Infect. 2000;76:173-6.
17. Lawton B, Rose S, Bromhead C, et al. Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women. N Z Med J. 2004;117(1194). URL: http://www.nzma.org.nz/journal/117-1194/889/
18. Division of STD Prevention. Chlamydia prevalence monitoring project. Annual report 2002. Sexually Transmitted Disease Surveillance 2002 Supplement. Atlanta, Georgia: Centers for Disease Control and Prevention. National Center for HIV, STD, and TB Prevention; 2003:1-17.
19. National Collaborating Centre for Women's and Children's Health. National Health Service. Antenatal care. Routine care for the healthy pregnant women. Clinical Guideline, October 2003. Available online. URL: http://www.nice.org.uk/page.aspx?o=CG006 Accessed March 2005.
20. Smith CD, Liu DTY, Jushuf IA, Hammond RH. Genital infection and termination of pregnancy: are patients still at risk? J Fam Plan Repro Hlth Care. 2001;27:81-4.
21. Fenton KA, LaMontagne DS, Randall S. National screening programme for chlamydia exists in England. BMJ. 2004;329:172.